Advertisement

Topics

Aimmune enters trial collaboration with Regeneron and Sanofi for peanut allergy therapy

15:40 EDT 17 Oct 2017 | Elsevier Business Intelligence

Aimmune Therapeutics Inc., Sanofi, and Regeneron Pharmaceuticals Inc. teamed up in a new trial collaboration to study the com...

Original Article: Aimmune enters trial collaboration with Regeneron and Sanofi for peanut allergy therapy

NEXT ARTICLE

More From BioPortfolio on "Aimmune enters trial collaboration with Regeneron and Sanofi for peanut allergy therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...